Cancer prevention research
that doesn't insult your intelligence.
We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments. Every claim gets an evidence grade. No supplements to sell. No miracle cures. Just research.
Our Evidence Grading System
Every compound and intervention gets a grade based on the quality of human clinical evidence, not animal studies or test tubes.
Latest Research
The Galleri Test: Is $950/yr Worth It?
A blood test that detects 50 cancer types. PATHFINDER 2 trial showed 7x cancer detection. We analyze what that actually means.
⭐ Grade A: Strong EvidenceHigh-Dose Melatonin: The 34% Mortality Reduction
Meta-analysis of 8 RCTs shows melatonin at 10-20mg reduced cancer mortality by 34%. No toxicity ever established.
🔬 Grade B: PromisingHigh-Dose IV Vitamin C: The Trial That Doubled Survival
A Phase II RCT doubled overall survival in metastatic pancreatic cancer. We break down the Iowa trial, mechanism, and what it means.
⭐ Grade A: Strong EvidenceMebendazole: The $5 Cancer Drug
An FDA-approved dewormer with Phase I/II trial data in glioblastoma and colorectal cancer. Crosses the blood-brain barrier.
🔬 Grade B: PromisingSulforaphane: The Nrf2 Activator From Broccoli Sprouts
Activates detox pathways. Phase II RCT signal in prostate cancer. 20-100x more potent in sprouts than mature broccoli.
🔬 Grade B: PromisingItraconazole: The Antifungal With Cancer Data
Antifungal with Phase II data in prostate cancer and NSCLC. Multi-target: Hedgehog, angiogenesis, mTOR.
🔬 Grade B: PromisingNew research reviews every month.
We track clinical trials, emerging compounds, and AI-driven cancer discoveries. Get updates when we publish new evidence reviews.